• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Recent Advances in the Study of 2,3-Dimethyl-4-nitro-benzonitrile (CAS: 52962-97-7): A Comprehensive Research Brief

2,3-Dimethyl-4-nitro-benzonitrile (CAS: 52962-97-7) is a nitrile-substituted aromatic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and material science. Recent studies have explored its potential as a key intermediate in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and antimicrobial agents. This research brief provides an in-depth analysis of the latest findings related to this compound, highlighting its chemical properties, synthetic routes, and biological activities.

One of the most notable advancements in the study of 2,3-Dimethyl-4-nitro-benzonitrile is its role in the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against cyclin-dependent kinases (CDKs), which are critical targets in cancer therapy. The researchers utilized a structure-activity relationship (SAR) approach to optimize the compound's scaffold, resulting in derivatives with improved selectivity and pharmacokinetic profiles. These findings underscore the potential of 2,3-Dimethyl-4-nitro-benzonitrile as a valuable building block for anticancer drug development.

In addition to its applications in oncology, recent research has also explored the antimicrobial properties of 2,3-Dimethyl-4-nitro-benzonitrile. A study conducted by a team at the University of Cambridge revealed that this compound exhibits broad-spectrum activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanism of action appears to involve disruption of bacterial cell wall synthesis, as evidenced by electron microscopy and molecular docking studies. These results suggest that 2,3-Dimethyl-4-nitro-benzonitrile could serve as a promising lead compound for the development of new antibiotics to address the growing threat of antimicrobial resistance.

From a synthetic chemistry perspective, recent efforts have focused on developing more efficient and sustainable routes to produce 2,3-Dimethyl-4-nitro-benzonitrile. A 2022 publication in Organic Process Research & Development described a green chemistry approach utilizing catalytic nitration and cyanation reactions, which significantly reduced the environmental impact of the synthesis. This method not only improved the yield and purity of the compound but also minimized the generation of hazardous byproducts, aligning with the principles of green chemistry.

Looking ahead, the potential applications of 2,3-Dimethyl-4-nitro-benzonitrile extend beyond pharmaceuticals. Emerging research in materials science has identified this compound as a precursor for the synthesis of organic semiconductors and liquid crystals. Its unique electronic properties, attributed to the nitro and nitrile functional groups, make it a promising candidate for use in optoelectronic devices. Ongoing studies are investigating its performance in organic light-emitting diodes (OLEDs) and photovoltaic cells, with preliminary results indicating high charge carrier mobility and thermal stability.

In conclusion, 2,3-Dimethyl-4-nitro-benzonitrile (CAS: 52962-97-7) represents a multifaceted compound with significant potential across multiple scientific disciplines. The latest research highlights its utility in drug discovery, antimicrobial development, and advanced materials, while also addressing the need for sustainable synthesis methods. As investigations into its properties and applications continue, this compound is poised to play an increasingly important role in addressing some of the most pressing challenges in chemical biology and pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)